by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
Involving more participants can lead to new medical insights Involving more participants can lead to new medical insights
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
Conditions: Long Term Follow-Up Interventions: Other: Long Term Follow-Up Sponsors: Calibr, a division of Scripps Research Not yet recruiting Conditions: Long Term Follow-Up Interventions: Other: Long Term Follow-Up Sponsors: Calibr, a division of Scripps Research...
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
Conditions: Carcinoma, Basal Cell (BCC) Interventions: Drug: Sonidegib Phosphate Capsules Sponsors: Jemincare; Sun Pharmaceutical Industries Limited; Zhejiang Hangyu Pharmaceutical Co., Ltd. Active, not recruiting Conditions: Carcinoma, Basal Cell (BCC)...
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
Conditions: Persistent Post-concussive Symptoms; Post Traumatic Headache Interventions: Other: SPINEPASS Physical Therapy; Other: Standard Physical Therapy Sponsors: The University of Queensland; Brooke Army Medical Center; United States Department of Defense Not...
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
Conditions: Torticollis Congenital; Motor Development; Sensory Integration Dysfunction Sponsors: Gazi University Recruiting Conditions: Torticollis Congenital; Motor Development; Sensory Integration Dysfunction Sponsors: Gazi University...
by palligoelme@gmail.com | Mar 18, 2025 | Clinical Trials
A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood cancers has shown a 73 per cent response rate among patients in India. Read on to know more. A new study published in The Lancet Haematology...
